Columbia University

Leading Experts Focus on the Challenges and Opportunities Affecting the Fight Against Cancer ALEXANDRIA, Va. ’€“ February 27, 2014 ’€“ A panel of leading health, economics and policy experts today discussed the prospects for a future where cancers are rendered manageable or even eradicated and the variables affecting progress toward that goal so that cancer patients are able to lead normal, productive lives ’€“ and thus be ’€œfree from’€ their cancers. The forum was hosted by Research!America and the Pancreatic Cancer Action Network. The event, titled, ’€œA World Free from Cancers: Probable, Possible, or Preposterous?’€ was held at the New York Academy of Sciences. Medical innovation has...
By Robert J. Hariri, MD, PhD, Chairman, Founder and Chief Scientific Officer of Celgene Cellular Therapeutics . Medical innovation is the source of dramatic improvements in the quality and length of life and also creates enormous value for society and the economy at large. For example, in 1900, the average U.S. life expectancy was 49 years. Today, it is 79. It is estimated by 2040, U.S. life expectancy will reach 85 years. This is primarily the result of innovation in medicine and improvements to public health. New medical treatments accounted for 45 percent of the increase in U.S. life expectancy between 1960 and 1997 and for nearly three-quarters of the increase in U.S life expectancy in...
By Robert J. Hariri, MD, PhD, Chairman, Founder and Chief Scientific Officer of Celgene Cellular Therapeutics . Medical innovation is the source of dramatic improvements in the quality and length of life and also creates enormous value for society and the economy at large. For example, in 1900, the average U.S. life expectancy was 49 years. Today, it is 79. It is estimated by 2040, U.S. life expectancy will reach 85 years. This is primarily the result of innovation in medicine and improvements to public health. New medical treatments accounted for 45 percent of the increase in U.S. life expectancy between 1960 and 1997 and for nearly three-quarters of the increase in U.S life expectancy in...
The Albert and Mary Lasker Foundation has announced the winners of its 2012 Awards : Albert Lasker Basic Medical Research Award: Michael Sheetz, PhD (Columbia University); James Spudich, PhD (Stanford University); and Ronald Vale, PhD (University of California San Francisco) Lasker~DeBakey Clinical Medical Research Award: Sir Roy Calne (University of Cambridge, emeritus); Thomas E. Starzl, MD, PhD (University of Pittsburgh) Lasker~Koshland Special Achievement Award: Donald D. Brown, DSc (Carnegie Institute); Tom Maniatis, PhD (Columbia University) The winners were announced Monday. The seven men will be honored at a ceremony September 21 in New York. “The Lasker Awards celebrate biomedical...